Race Matters in MS Progression Among Women
WEDNESDAY, Jan. 24, 2024 -- Young Black and Hispanic women diagnosed with multiple sclerosis are more likely to fare worse than young white women do, a new study shows.
Specifically, they are more likely to have advanced MS and to face greater... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 24, 2024 Category: General Medicine Source Type: news
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
The announcement follows the recent IND clearance for KYV-101 to be used in Kyverna's KYSA-7 Phase 2 open-label, multicenter study
KYV-101 is a fully human CD19 CAR T-cell therapy designed for use in patients with B cell-driven autoimmune diseases
EM... Regenerative Medicine, Neurology, FDA Kyverna Therapeutics, multiple sclerosis, CAR T-cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2024 Category: Pharmaceuticals Source Type: news
The role of sensory systems in the association between balance and walking in people with multiple sclerosis - Tacchino A, Skjerb æk AG, Podda J, Prada V, Monti Bragadin M, Bergamaschi V, Susini A, Hvid LG, Pedullà L, Brichetto G.
BACKGROUND: In Multiple Sclerosis, it has been demonstrated that balance is related to performances in walking tasks at different levels of complexity. However, it is unknown how the different sensory systems involved in balance control contribute to walki... (Source: SafetyLit)
Source: SafetyLit - January 16, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Usefulness of the Berg Balance Scale for prediction of fall risk in multiple sclerosis - Ayvat E, Do ğan M, Ayvat F, Kılınç O, Sutcu G, Kılınç M, Yıldırım SA.
INTRODUCTION: The Berg Balance Scale, possibly the most widely used balance-related measure, has gained popularity in clinical trials. It provides information about patients' balance-related abilities and can be used to assess improvement or worsening afte... (Source: SafetyLit)
Source: SafetyLit - January 15, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Myrobalan raises $24M round to bring central nervous system drug into clinic
A biotech developing an oral drug to repair damage and restore neural function in patients with such conditions as Alzheimer ’s disease, ALS and multiple sclerosis has raised a round of venture capital.
Myrobalan Therapeutics of Medford, Mass. announced a $24 million Series A investment round on Wednesday morning. The round was led by Co-win Healthcare Fund of China, alongside new and existing investors, including 3E B ioventures Capital, AB Magnitude Ventures Group and Guan Zi Equity Investment… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 11, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news
All Pain Is Not the Same When It Comes to MS
THURSDAY, Jan. 11, 2024 -- Pain can present itself in many forms for people battling multiple sclerosis, and one type can interfere with exercising, new research shows.
One class of pain experienced by MS patients is what the authors of the new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 11, 2024 Category: General Medicine Source Type: news
Ancient steppe herders brought higher risk of MS to northern Europe
Study of ancient DNA shows bronze age Yamnaya people spread gene variants that carry increased risk of multiple sclerosisAncient DNA helps explain why northern Europeans have a higher risk of multiple sclerosis than other ancestries: the disease is a genetic legacy of horseback-riding cattle herders who swept into the region about 5,000 years ago.The findings come from a huge project to compare modern DNA with that culled from ancient humans ’ teeth and bones – allowing scientists to trace prehistoric migration and disease-linked genes that tagged along.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 10, 2024 Category: Science Authors: AP in Washington Tags: Genetics Multiple sclerosis Genealogy Biology Science Source Type: news
MS Risk Linked to Ancient Migrations
(MedPage Today) -- Genetic risk for multiple sclerosis (MS) was brought into Europe by sheep and cattle herders migrating from the east approximately 5,000 years ago, DNA profiles from archaeological bones and teeth suggested.
Migration among... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - January 10, 2024 Category: Neurology Source Type: news
Ancient human DNA hints at why multiple sclerosis affects so many northern Europeans today
Northern Europeans more prone to multiple sclerosis than other ancestries and now a study of ancient DNA hints at why (Source: ABC News: Health)
Source: ABC News: Health - January 10, 2024 Category: Consumer Health News Tags: Health Source Type: news
Ancient Skeletons Give Clues to Modern Medical Mysteries
DNA fragments from thousands of years ago are providing insights into multiple sclerosis, diabetes, schizophrenia and other illnesses. (Source: NYT Health)
Source: NYT Health - January 10, 2024 Category: Consumer Health News Authors: Carl Zimmer Tags: your-feed-science Research Genetics and Heredity Multiple Sclerosis Nomadic People Autoimmune Diseases Source Type: news
Myrobalan raises early VC round to bring central nervous system drug into clinic
A Medford biotech developing an oral drug to repair damage and restore neural function in patients with such conditions as Alzheimer ’s disease and multiple sclerosis has raised a round of venture capital. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 10, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news
More Insight Into How a Virus Might Cause MS
MONDAY, Jan. 8, 2024 -- There ' s information emerging on how the common Epstein-Barr virus (EBV) might be crucial to triggering multiple sclerosis (MS).The virus, which also causes " mono " (mononucleosis) and other illnesses, has gained prominence in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 8, 2024 Category: General Medicine Source Type: news
Neurologic Disabilities Linked to Long COVID Risks
(MedPage Today) -- Some long COVID symptoms were more likely for persons with multiple sclerosis (MS), traumatic brain injury (TBI), or spinal cord injury (SCI), a retrospective cohort study found.
After having COVID-19, such patients with preexisting... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 5, 2024 Category: Infectious Diseases Source Type: news
Smartphone-based gait assessment for multiple sclerosis - Regev K, Eren N, Yekutieli Z, Karlinski K, Massri A, Vigiser I, Kolb H, Piura Y, Karni A.
INTRODUCTION: Multiple Sclerosis causes gait alteration, even in the early stages of the disease. Traditional methods to quantify gait impairment, such as performance-based measures, lab-based motion analyses, and self-report, have limited ecological relev... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Among a biotech space bursting with innovation, one company stands out as it is developing two assets at once: a ready-for-market drink that can take someone from a drinking state to mental and physical composure in record time and a potential breakthrough therapy for Multiple Sclerosis. Meet FSD…#multiplesclerosis #cse #zeeshansaeed #fsd #lucidpsycheceutical #lucid #universityoftoronto #stanford #ontario #unbuzzd (Source: Reuters: Health)
Source: Reuters: Health - December 22, 2023 Category: Consumer Health News Source Type: news
